rs104894210
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The NM_001814.6(CTSC):c.116G>C(p.Trp39Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000019 in 1,576,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )
Consequence
CTSC
NM_001814.6 missense
NM_001814.6 missense
Scores
15
3
1
Clinical Significance
Conservation
PhyloP100: 6.65
Genes affected
CTSC (HGNC:2528): (cathepsin C) This gene encodes a member of the peptidase C1 family and lysosomal cysteine proteinase that appears to be a central coordinator for activation of many serine proteinases in cells of the immune system. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate heavy and light chains that form a disulfide-linked dimer. A portion of the propeptide acts as an intramolecular chaperone for the folding and stabilization of the mature enzyme. This enzyme requires chloride ions for activity and can degrade glucagon. Defects in the encoded protein have been shown to be a cause of Papillon-Lefevre syndrome, an autosomal recessive disorder characterized by palmoplantar keratosis and periodontitis. [provided by RefSeq, Nov 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.994
PP5
Variant 11-88337557-C-G is Pathogenic according to our data. Variant chr11-88337557-C-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 7296.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr11-88337557-C-G is described in UniProt as null. Variant chr11-88337557-C-G is described in UniProt as null. Variant chr11-88337557-C-G is described in UniProt as null. Variant chr11-88337557-C-G is described in UniProt as null. Variant chr11-88337557-C-G is described in UniProt as null. Variant chr11-88337557-C-G is described in UniProt as null. Variant chr11-88337557-C-G is described in UniProt as null. Variant chr11-88337557-C-G is described in UniProt as null. Variant chr11-88337557-C-G is described in UniProt as null. Variant chr11-88337557-C-G is described in UniProt as null. Variant chr11-88337557-C-G is described in UniProt as null. Variant chr11-88337557-C-G is described in UniProt as null. Variant chr11-88337557-C-G is described in UniProt as null. Variant chr11-88337557-C-G is described in UniProt as null. Variant chr11-88337557-C-G is described in UniProt as null. Variant chr11-88337557-C-G is described in UniProt as null. Variant chr11-88337557-C-G is described in UniProt as null. Variant chr11-88337557-C-G is described in UniProt as null. Variant chr11-88337557-C-G is described in UniProt as null. Variant chr11-88337557-C-G is described in UniProt as null. Variant chr11-88337557-C-G is described in UniProt as null. Variant chr11-88337557-C-G is described in UniProt as null.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTSC | NM_001814.6 | c.116G>C | p.Trp39Ser | missense_variant | 1/7 | ENST00000227266.10 | NP_001805.4 | |
CTSC | NM_001114173.3 | c.116G>C | p.Trp39Ser | missense_variant | 1/4 | NP_001107645.1 | ||
CTSC | NM_148170.5 | c.116G>C | p.Trp39Ser | missense_variant | 1/4 | NP_680475.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTSC | ENST00000227266.10 | c.116G>C | p.Trp39Ser | missense_variant | 1/7 | 1 | NM_001814.6 | ENSP00000227266 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152228Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
152228
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000107 AC: 2AN: 187450Hom.: 0 AF XY: 0.00000994 AC XY: 1AN XY: 100562
GnomAD3 exomes
AF:
AC:
2
AN:
187450
Hom.:
AF XY:
AC XY:
1
AN XY:
100562
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000140 AC: 2AN: 1424558Hom.: 0 Cov.: 32 AF XY: 0.00000142 AC XY: 1AN XY: 705038
GnomAD4 exome
AF:
AC:
2
AN:
1424558
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
705038
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152228Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74370
GnomAD4 genome
AF:
AC:
1
AN:
152228
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74370
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:2Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Papillon-Lefèvre syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2001 | - - |
Papillon-Lefèvre syndrome;C1855627:Haim-Munk syndrome;C4551681:Periodontitis, aggressive 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | This sequence change replaces tryptophan, which is neutral and slightly polar, with serine, which is neutral and polar, at codon 39 of the CTSC protein (p.Trp39Ser). This variant is present in population databases (rs104894210, gnomAD 0.01%). This missense change has been observed in individual(s) with Papillon-Lefevre syndrome (PMID: 11180012). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 7296). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant disrupts the p.Trp39 amino acid residue in CTSC. Other variant(s) that disrupt this residue have been observed in individuals with CTSC-related conditions (PMID: 27062382), which suggests that this may be a clinically significant amino acid residue. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
CTSC-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 17, 2024 | The CTSC c.116G>C variant is predicted to result in the amino acid substitution p.Trp39Ser. This variant has been reported in the homozygous state in four individuals with Papillon-Lefevre syndrome from the same family (Family 1, Nakano et al. 2001. PubMed ID: 11180012). This variant is reported in 0.011% of alleles in individuals of Ashkenazi Jewish descent in gnomAD. Of note, another variant impacting the same amino acid [c.117G>T (Trp39Cys)] has also been reported in the homozygous state in an individual with Papillon-Lefevre syndrome (Tekin et al. 2016. PubMed ID: 27062382). Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;.;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M;M;M
MutationTaster
Benign
A;A;A
PrimateAI
Pathogenic
T
PROVEAN
Pathogenic
D;D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
D;P;.
Vest4
MutPred
Gain of disorder (P = 0.0037);Gain of disorder (P = 0.0037);Gain of disorder (P = 0.0037);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at